The miR-17 ∼ 92 microRNA Cluster Is a Global Regulator of Tumor Metabolism | Zendy

Said Izreig | Zendy; Bożena Samborska | Zendy; Radia Marie Johnson | Zendy; Alexey Sergushichev | Zendy; H. Eric | Zendy; Carine Lussier | Zendy; Ekaterina Loginicheva | Zendy; Ariel O. Donayo | Zendy; Maya C. Poffenberger | Zendy; Selena M. Sagan | Zendy; Emma E. Vincent | Zendy; Maxim N. Artyomov | Zendy; Thomas F. Duchaîne | Zendy; Russell G. Jones | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The miR-17 ∼ 92 microRNA Cluster Is a Global Regulator of Tumor Metabolism

Author(s) -

Said Izreig,

Bożena Samborska,

Radia Marie Johnson,

Alexey Sergushichev,

H. Eric,

Carine Lussier,

Ekaterina Loginicheva,

Ariel O. Donayo,

Maya C. Poffenberger,

Selena M. Sagan,

Emma E. Vincent,

Maxim N. Artyomov,

Thomas F. Duchaîne,

Russell G. Jones

Publication year - 2016

Publication title -

cell reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.264

H-Index - 154

eISSN - 2639-1856

pISSN - 2211-1247

DOI - 10.1016/j.celrep.2016.07.036

Subject(s) - microrna , biology , mtorc1 , reprogramming , microbiology and biotechnology , cancer research , regulator , glycolysis , tumor progression , tumor microenvironment , metabolism , cell growth , suppressor , cell , cancer , tumor cells , signal transduction , biochemistry , genetics , pi3k/akt/mtor pathway , gene

A central hallmark of cancer cells is the reprogramming of cellular metabolism to meet the bioenergetic and biosynthetic demands of malignant growth. Here, we report that the miR-17∼92 microRNA (miRNA) cluster is an oncogenic driver of tumor metabolic reprogramming. Loss of miR-17∼92 in Myc(+) tumor cells leads to a global decrease in tumor cell metabolism, affecting both glycolytic and mitochondrial metabolism, whereas increased miR-17∼92 expression is sufficient to drive increased nutrient usage by tumor cells. We mapped the metabolic control element of miR-17∼92 to the miR-17 seed family, which influences cellular metabolism and mammalian target of rapamycin complex 1 (mTORC1) signaling through negative regulation of the LKB1 tumor suppressor. miR-17-dependent tuning of LKB1 levels regulates both the metabolic potential of Myc(+) lymphomas and tumor growth in vivo. Our results establish metabolic reprogramming as a central function of the oncogenic miR-17∼92 miRNA cluster that drives the progression of MYC-dependent tumors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research